江天化学(300927) - 2024 Q3 - 季度财报

Financial Performance - The company's operating revenue for Q3 2024 was ¥169,505,055.44, an increase of 0.14% year-on-year, while the revenue for the year-to-date period was ¥521,841,290.11, a decrease of 1.47% compared to the same period last year [2]. - Net profit attributable to shareholders for Q3 2024 was ¥8,885,885.60, down 39.47% year-on-year, and the year-to-date net profit was ¥33,988,850.08, a decrease of 37.00% [2]. - The net profit attributable to shareholders after deducting non-recurring gains and losses for Q3 2024 was ¥7,719,874.29, a decline of 46.49% year-on-year, with a year-to-date figure of ¥32,317,244.29, down 39.01% [2]. - The basic earnings per share for Q3 2024 was ¥0.0616, a decrease of 39.43% year-on-year, and the diluted earnings per share was also ¥0.0616, reflecting the same percentage decline [2]. - Total operating revenue for Q3 2024 was CNY 521,841,290.11, a decrease of 1.5% compared to CNY 529,615,220.27 in the same period last year [11]. - Net profit for Q3 2024 was CNY 33,988,850.08, down 37% from CNY 53,952,613.65 in Q3 2023 [12]. - The basic and diluted earnings per share for Q3 2024 are both ¥0.2354, down from ¥0.3737 in the previous year, indicating a decrease of about 37% [13]. Cash Flow and Liquidity - The net cash flow from operating activities for the year-to-date period was ¥18,390,885.93, down 71.53% compared to the previous year [2]. - As of September 30, 2024, the company's cash and cash equivalents amounted to ¥274,074,959.92, down from ¥322,396,940.83 at the beginning of the period, indicating a decrease of approximately 14.93% [9]. - Cash inflow from operating activities for Q3 2024 totals ¥517,903,000.03, compared to ¥543,123,724.01 in the same period last year, reflecting a decrease of approximately 4.6% [15]. - The net cash flow from operating activities for Q3 2024 is ¥18,390,885.93, significantly lower than ¥64,601,851.64 in the previous year, marking a decline of about 71.5% [15]. - The net cash flow from investing activities for Q3 2024 is -¥269,031,013.42, worsening from -¥199,742,937.30 in the same period last year [15]. - Cash and cash equivalents at the end of Q3 2024 amount to ¥274,074,959.92, an increase from ¥187,343,574.67 at the end of the previous year [16]. - The company reported a cash flow decrease of ¥48,321,980.91 in cash and cash equivalents for Q3 2024, compared to a decrease of ¥117,481,646.78 in the previous year [16]. Assets and Liabilities - Total assets at the end of Q3 2024 amounted to ¥1,399,075,019.58, representing a 39.83% increase from the end of the previous year [2]. - Total liabilities increased to CNY 697,845,255.44, up from CNY 314,457,973.57, representing a rise of 122.5% [11]. - The total equity attributable to shareholders was CNY 701,229,764.14, up from CNY 686,071,863.95, an increase of 2.1% [11]. Government Subsidies and Financial Gains - The company received government subsidies amounting to ¥135,542.48 in Q3 2024, with a total of ¥218,506.46 for the year-to-date period [3]. - The fair value changes of financial assets and liabilities resulted in a gain of ¥1,341,700.38 for Q3 2024, with a total of ¥1,941,242.02 for the year-to-date period [3]. Strategic Acquisition - The company plans to acquire 100% equity of San Da Ya Fine Chemicals (Nantong) Co., Ltd. through cash, which will become a wholly-owned subsidiary upon completion of the transaction [7]. - The acquisition will expand the company's product structure to include superabsorbent resin, targeting the consumer chemical sector and enhancing customer diversification [8]. - The company has completed the supplementary and revised disclosure documents related to the acquisition, with the financial data of the target company audited as of June 30, 2024 [8]. - The acquisition does not involve issuing new shares and will not change the company's control [8]. - The company is enhancing its risk resistance and sustainable development capabilities through this strategic acquisition [8]. - The financial data of the target company has been reviewed and is compliant with relevant legal regulations [8]. - The company will continue to disclose information regarding the progress of the acquisition to ensure transparency for investors [8]. Research and Development - Research and development expenses decreased to CNY 3,566,172.12 from CNY 5,131,787.29, a reduction of 30.6% year-on-year [12]. - The company plans to focus on market expansion and new product development in the upcoming quarters [10]. Shareholder Information - The major shareholders include Nantong Industrial Holding Group Co., Ltd. with a 37.53% stake and Nantong Xinyuan Investment Development Co., Ltd. with a 15.02% stake [6]. - The company has not reported any changes in the top 10 shareholders due to securities lending activities [7].